Full Text View
Tabular View
Study Results
Related Studies
SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study
This study has been completed.
Study NCT00511797   Information provided by Bayer

First Received on August 3, 2007.   Last Updated on December 26, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dysmenorrhea
More general conditions related to this trial
Menstruation Disturbances
Pain
Pathologic Processes
Pelvic Pain
Signs and Symptoms
Interventions listed in this trial
SH T04740B
SH T00186DF
SH T04740F
Placebo
Additional drug interventions recognized in this trial
Drospirenone
Ethinyl Estradiol
More general drug interventions related to this trial
Aldosterone Antagonists
Estrogens
Hormone Antagonists
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services